Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 9/20 | 0.42 |
| ▸ | GPR6 | P46095 | 4/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 3/20 | 0.36 |
| ▸ | ERBB2 | P04626 | 3/20 | 0.36 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.34 |
| ▸ | FLT1 | P17948 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL389581 | 0.90 | GPR119 (0.52) | GPR119CYP2C9KCNH2EGFR | |
| SCHEMBL3254476 | 0.89 | GPR119 (0.45) | GPR119GPR6CYP2C9KCNH2ERBB2 | |
| SCHEMBL14458861 | 0.86 | GPR119 (0.58) | GPR119CYP2C9KCNH2 | |
| SCHEMBL5822810 | 0.85 | GPR119 (0.45) | GPR119GPR6CYP2C9KCNH2EGFR | |
| SCHEMBL3253994 | 0.82 | ACACB (0.42) | GPR119EGFRERBB2 | |
| SCHEMBL3252589 | 0.81 | GPR119 (0.41) | GPR119GPR6CYP2C9KCNH2EGFR | |
| SCHEMBL3252680 | 0.81 | GPR119 (0.39) | GPR119GPR6CYP2C9KCNH2EGFR | |
| SCHEMBL5050891 | 0.80 | FLT1 (0.38) | GPR119EGFRFGFR1FLT1KDR | |
| SCHEMBL3252644 | 0.80 | ACACB (0.39) | GPR119GPR6CYP2C9KCNH2ERBB2 | |
| SCHEMBL3252397 | 0.80 | GPR6 (0.45) | GPR119GPR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1911756-B9 | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto | ARENA PHARM INC (US) | 2010-05-26 | — | — | EP | claimed |
| EP-1911756-B1 | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto | ARENA PHARM INC (US) | 2009-10-21 | — | — | EP | claimed |
| EP-1732562-B1 | SUBSTITUTED PYRIDINYL AND PYRIMIDINYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARM INC (US) | 2007-12-19 | — | — | EP | claimed |